{"id":"W4321611533","doi":"10.1007/s40744-023-00533-5","title":"Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study","year":2023,"lang":"en","type":"article","venue":"Rheumatology and Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Saskatchewan","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Golimumab; Infliximab; Observational study; Rheumatoid arthritis; Medicine; Phase (matter); Physical therapy; Internal medicine; Adalimumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006992713,0.0003345915,0.0007512106,0.0003404554,0.0003335849,0.00006664784,0.0001703371,0.00009554785,0.0001166218],"category_scores_gemma":[0.0003114884,0.0001924574,0.00005376176,0.0008863828,0.0002188992,0.0001333241,0.00005454014,0.0002397738,0.00006340173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001066859,"about_ca_system_score_gemma":0.0004230743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003874465,"about_ca_topic_score_gemma":0.01054719,"domain_scores_codex":[0.9971589,0.0006115105,0.0006656656,0.0006021229,0.0004000761,0.0005617039],"domain_scores_gemma":[0.9972504,0.001698011,0.0001280646,0.0005431476,0.0001570529,0.0002233521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1851872,0.004039317,0.6057324,0.000006636918,0.0005156735,0.0005493392,0.02636013,0.000008956089,0.000151382,0.0001406182,0.0007942196,0.1765142],"study_design_scores_gemma":[0.1267158,0.02259112,0.8155475,0.0007700044,0.00000386799,0.0001097675,0.00430064,0.0001796121,0.0002405051,0.0003313765,0.02881855,0.0003912878],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893116,0.001300867,0.000004915777,0.006234141,0.00007947532,0.002605614,0.0002754712,0.0001480309,0.00003991595],"genre_scores_gemma":[0.9053751,0.0931052,0.00007133887,0.000264818,0.00001216118,0.0006429889,0.0003084367,0.00004288772,0.000177137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2098151,"threshold_uncertainty_score":0.7848184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04390652984428994,"score_gpt":0.3296015249212063,"score_spread":0.2856949950769163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}